Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

DexCom, Inc. - Common Stock (NQ:DXCM)

62.21 -5.93 (-8.70%)
Streaming Delayed Price Updated: 1:20 PM EDT, Apr 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about DexCom, Inc. - Common Stock

< Previous 1 2
...
27 28 29 30 31 32 33 34 Next >
Why Senseonics Shares Are Rocketing Higher After Hours Thursday
Study results from a glucose monitoring company were reported after market close Thursday. What Happened: Medical technology company Senseonics Holdings (NYSE: SENS) reported... 
Via Benzinga
Dexcom Looks to the Future of Continuous Glucose Monitoring
From DexCom, Inc.
Via Business Wire
Where DexCom Stands With Analysts
Analysts have provided the following ratings for DexCom (NASDAQ:DXCM) within the last quarter: Last 30 Days 1 Month Ago 2 Months Ago 3 Months Ago Bullish 0 2 0 0... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 28, 2021
Upgrades For Delek US Holdings Inc (NYSE:DK), Tudor Pickering upgraded the previous rating of Hold to Buy. For the first quarter, Delek US Hldgs had an EPS of $1.69,... 
Via Benzinga
Dexcom Announces Upcoming Conference Presentation
From DexCom, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2021
Upgrades For Appian Corp (NASDAQ:APPN), Macquarie upgraded the previous rating of Underperform to Neutral. For the first quarter, Appian had an EPS of $0.06, compared to... 
Via Benzinga
Why DexCom Stock Jumped Today
No news was good news for the healthcare stock. 
Via The Motley Fool
3 Top Healthcare Stocks to Buy Right Now
These three healthcare stocks have proven that growth and long-term trends are on their side. 
Via The Motley Fool
These 7 Medical Stocks Are Breaking Down — The Sell Rule You Should Know
Former high-flyers Dexcom and Tandem Diabetes are among seven health care stocks breaking down right now, according to MarketSmith.com. 
Via Investor's Business Daily
2 Top Growth Stocks on Sale After Earnings
For these two companies, the bull case remains intact. 
Via The Motley Fool
38 Stocks Moving In Friday's Mid-Day Session
Gainers Image Sensing Systems, Inc. (NASDAQ: ISNS) rose 29.2% to $5.93 after the company announced it initiated a quarterly dividend of $0.12 per share, authorized a 220,000... 
Via Benzinga
55 Biggest Movers From Friday
Gainers Brooklyn ImmunoTherapeutics, Inc. (NYSE: BTX) jumped 45.5% to close at $49.80 on Friday after dropping around 22% on Thursday. Brooklyn ImmunoTherapeutics acquired... 
Via Benzinga
Why DexCom Stock Is Dropping Today
Investors were not pleased with the company's latest earnings report. 
Via The Motley Fool
22 Stocks Moving in Friday's Pre-Market Session
Gainers Image Sensing Systems, Inc. (NASDAQ: ISNS) rose 30.7% to $6.00 in pre-market trading after the company announced it initiated a quarterly dividend of $0.12 per share,... 
Via Benzinga
The Daily Biotech Pulse: Hyperphosphatemia Drug Regulatory Review Extended, Phathom Pharma Data Readout, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 29) AtriCure, Inc. (NASDAQ:... 
Via Benzinga
Dexcom Inc (DXCM) Q1 2021 Earnings Call Transcript
DXCM earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
15 Stocks Moving In Thursday's After-Hours Session
Gainers Amazon (NASDAQ: AMZN) shares are trading higher after the company reported better-than-expected Q1 EPS and sales results. The company also issued Q2 sales guidance above... 
Via Benzinga
Recap: DexCom Q1 Earnings
Shares of DexCom (NASDAQ:DXCM) fell in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share were down 25.00% over the past year to... 
Via Benzinga
Dexcom Beats First-Quarter Expectations, But Shares Tumble
Dexcom stock tumbled late Thursday after the diabetes devices company reported adjusted earnings of 33 cents per share on $505 million in sales. 
Via Investor's Business Daily
Dexcom Reports First Quarter 2021 Financial Results
From DexCom, Inc.
Via Business Wire
3 Unstoppable Growth Stocks You Can Hold for Decades
Each proved its worth during the coronavirus pandemic. 
Via The Motley Fool
Exposures COVID-19
Senseonics Stock Will Likely Rise on the Same Trajectory As DexCom
Senseonics will rise on the same trajectory as DexCom. SENS stock could rise 5 to 10 times over the next 5 years with FDA approval. 
Via InvestorPlace
Exposures Product Safety
The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 28) Axonics, Inc. (NASDAQ:... 
Via Benzinga
The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx
Biopharma stocks came back from the weakness seen in the first two sessions to close the week ended April 23 higher. Johnson & Johnson (NYSE: JNJ) and Roche Holding AG (OTC:... 
Via Benzinga
Exposures Product Safety
Benzinga's Top Ratings Upgrades, Downgrades For April 15, 2021
Upgrades According to JP Morgan, the prior rating for Vipshop Holdings Ltd (NYSE:VIPS) was changed from Neutral to Overweight. In the fourth quarter, Vipshop Holdings... 
Via Benzinga
< Previous 1 2
...
27 28 29 30 31 32 33 34 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.